Safety and feasibility of hyperthermic intraperitoneal chemotherapy during interval cytoreductive surgery in patients with advanced high-grade serous ovarian, fallopian tube, peritoneal cancer in an Australian context.

MLA

Samoylovich, Arthur, et al. “Safety and Feasibility of Hyperthermic Intraperitoneal Chemotherapy during Interval Cytoreductive Surgery in Patients with Advanced High-Grade Serous Ovarian, Fallopian Tube, Peritoneal Cancer in an Australian Context.” The Australian & New Zealand Journal of Obstetrics & Gynaecology, vol. 63, no. 5, Oct. 2023, pp. 702–08. EBSCOhost, https://doi.org/10.1111/ajo.13694.

APA

Samoylovich, A., Jennings, B., Shannon, C., Coward, J. I., Lourie, R., Riordan, J., Lai, N. A., van Driel, W. J., Cabraal, N., Jagasia, N., Chetty, N., Naidu, S., Perrin, L. C., & Barry, S. C. (2023). Safety and feasibility of hyperthermic intraperitoneal chemotherapy during interval cytoreductive surgery in patients with advanced high-grade serous ovarian, fallopian tube, peritoneal cancer in an Australian context. The Australian & New Zealand Journal of Obstetrics & Gynaecology, 63(5), 702–708. https://doi.org/10.1111/ajo.13694

Chicago

Samoylovich, Arthur, Bronwyn Jennings, Catherine Shannon, Jermaine I Coward, Rohan Lourie, John Riordan, Nai An Lai, et al. 2023. “Safety and Feasibility of Hyperthermic Intraperitoneal Chemotherapy during Interval Cytoreductive Surgery in Patients with Advanced High-Grade Serous Ovarian, Fallopian Tube, Peritoneal Cancer in an Australian Context.” The Australian & New Zealand Journal of Obstetrics & Gynaecology 63 (5): 702–8. doi:10.1111/ajo.13694.